Qube Research & Technologies Ltd

Position in CRBU — Caribou Biosciences, Inc.

CIK 1729829 LONDON, X0

Position in CRBU

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$335,724

+$10,328 QoQ

Shares Held

176,697

-13.7% QoQ

Ownership

0.178%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 137 holders

Holding Since

Mar 2022

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. CRBU ranks #146 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$335,724	176,697	-13.7%	Shares	Sole	2026-05-15
2025-12-31	$325,396	204,652	+353.3%	Shares	Sole	2026-02-17
2025-09-30	$105,199	45,150	-79.5%	Shares	Sole	2025-11-14
2024-06-30	$360,827	220,017	+163.1%	Shares	Sole	2024-08-14
2023-06-30	$355,351	83,612	+248.0%	Shares	Sole	2023-08-14
2022-12-31	$150,877	24,025	+67.7%	Shares	Sole	2023-02-14
2022-06-30	$77,790	14,326	-71.5%	Shares	Sole	2022-08-15
2022-03-31	$461,368	50,258	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.